Manning Amends Verrica Pharma Stake Filing

TL;DR

Manning updated his Verrica Pharma (VRCA) filing, watch for more details on his stake.

AI Summary

Paul B. Manning, through PBM Capital Group, LLC, has amended their Schedule 13D filing for Verrica Pharmaceuticals Inc. on November 26, 2024. This amendment indicates a change in beneficial ownership of the company's common stock. The filing does not specify the exact percentage or number of shares now held, but it signifies an update to Manning's stake.

Why It Matters

Changes in significant shareholder filings like this can signal shifts in control or strategy, potentially impacting the stock price and future corporate actions of Verrica Pharmaceuticals.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate events or changes in control, which can introduce volatility.

Key Players & Entities

• Verrica Pharmaceuticals Inc. (company) — Subject company
• Paul B. Manning (person) — Filing person
• PBM Capital Group, LLC (company) — Associated entity for Paul B. Manning
• BKB GROWTH INVESTMENTS, LLC (company) — Group member
• PBM CAPITAL INVESTMENTS, LLC (company) — Group member

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
• $0.89 — mmon Stock. Each unit was purchased for $0.89. (d) Except as set forth herein, no

Filing Documents

• tm2429593d1_sc13da.htm (SC 13D/A) — 63KB
• 0001104659-24-123093.txt ( ) — 64KB

From the Filing

SC 13D/A 1 tm2429593d1_sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Verrica Pharmaceuticals Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 92511W108 (CUSIP Number) Paul B. Manning c/o PBM Capital Group, LLC 200 Garrett Street, Suite S Charlottesville, VA 22902 (434) 980-8100 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 22, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 92511W108 1. Names of Reporting Persons Paul B. Manning 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) ¨ x 3. SEC Use Only 4. Source of Funds (See Instructions) PF 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ 6. Citizenship or Place of Organization United States Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 43,695,934 (1) 8. Shared Voting Power 8,808,115 (2) 9. Sole Dispositive Power 43,695,934 (1) 10. Shared Dispositive Power 8,808,115 (2) 11. Aggregate Amount Beneficially Owned by Each Reporting Person 52,504,049 (1)(2) 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ 13. Percent of Class Represented by Amount in Row (11) 49.9% (3) 14. Type of Reporting Person (See Instructions) IN (1) Consists of: (i) 25,828,094 shares of the Issuer’s common stock held by Paul and Diane Manning, JTWROS;(ii) 3,324,338.75 shares of the Issuer’s common stock held by The Paul B. Manning Revocable Trust dated May 10, 2000; (iii) 256,634 shares of the Issuer’s common stock held by PBM Capital Investments, LLC; (iv) 2,675,611.25 shares of the Issuer’s common stock held by separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust; (v) 11,611,256 shares of the Issuer’s common stock issuable upon the exercise of warrants within 60 days of November 22, 2024. (2) Consists of (i) 5,976,101 shares of the Issuer's common stock and (ii) 2,832,014 shares of the Issuer’s common stock issuable upon the exercise of warrants within 60 days of November 22, 2024 held by BKB Growth Investments, LLC. (3) This percentage is calculated based upon 90,564,840 shares of the Issuer’s common stock outstanding as of November 22, 2024, as reported in the Prospectus Supplement filed by the Issuer on November 21, 2024. 2 CUSIP No. 92511W108 1. Names of Reporting Persons PBM Capital Investments, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) ¨ x 3. SEC Use Only 4. Source of Funds (See Instructions) AF 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ¨ 6. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 7. Sole Voting Power 256,634 8. Shared Voting Power 0 9. Sole Dispositive Power 256,634 10. Shared Dispositive Power 0 11. Aggregate Amount Beneficially Owned by Each Reporting Person 256,634 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ¨ 13. Percent of Class Represented by Amount in Row (11) 0.3% (1) 14. Type of Reporting Person (See Instructions) OO (1) This percentage is calculated based upon 90,564,840 shares of the Issuer’s common stock outstanding as of November 22, 2024, as reported in the Prospectus Supplement filed by the Issuer on November 21, 2024. 3 CUSIP No. 92511W108 1. Names of Reporting Persons BKB Growth Inve

View Full Filing

View this SC 13D/A filing on SEC EDGAR